# ViroVet NV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virovet

- Industry: Biotechnology
- Headquarters: Leuven, Belgium
- Total disclosed funding: $9.8M
- Latest round: Series B (May 28, 2020)
- Investors on record: 7

## About

Founded in 2015 and based in Belgium, ViroVet NV operates as a biopharmaceutical company, providing vaccines and antiviral drugs for livestock industry.

## Funding rounds

- Series B, May 28, 2020, $6.7M — Capricorn Partners, K.U. Leuven Research & Development, Seventure Partners, Vives, PMV, Agri Investment Fund
- Series A, Jan 17, 2017, $3.2M — Capricorn Partners, K.U. Leuven Research & Development, Vives, PMV, Aratana Therapeutics, Inc., Agri Investment Fund

## Investors

- Capricorn Partners (https://capitalatlas.ai/funds/capricorn-partners) — Series A, Series B
- K.U. Leuven Research & Development (https://capitalatlas.ai/funds/k-u-leuven-research-development) — Series A, Series B
- Vives (https://capitalatlas.ai/funds/vives) — Series A, Series B
- PMV (https://capitalatlas.ai/funds/pmv) — Series A, Series B
- Aratana Therapeutics, Inc. — Series A
- Agri Investment Fund (https://capitalatlas.ai/funds/agri-investment-fund) — Series A, Series B
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series B